Familial hypercholesterolaemia (FH) presents a significant risk for early cardiovascular morbidity and mortality. Several new international guidelines on FH have been published in the last year and similarities and differences between them are described and summarised in this review. New European guidelines discuss other familial dyslipidaemias as well as FH. These guidelines should improve the quality and cost effectiveness of care provided.
Get full access to this article
View all access options for this article.
References
1.
National Institute for Health and Clinical Excellence. Identification and management of familial hypercholesterolaemia. Clinical Guidance 71 2008. London: NICE2008. http://guidance.nice.org.uk/CG71/Guidance/pdf/English (Accessed May 2012)
2.
GoldbergACHopkinsPNTothPP. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol2011;5(3 suppl):S1-8.
3.
WattsGFSullivanDRPoplawskiN. Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl2011;12: 221-63.
4.
CatapanoALReinerZDe BackerG. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis2011;217:3-46.
5.
DescampsOSTenoutasseSStephenneX. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis2011;218:272-80.
WiegmanAHuttenBAde GrootE. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA2004;292:331-7.
8.
FriedmanLAMorrisonJADanielsSR. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up Study. Pediatrics2006;118:165-72.
9.
FreedmanDSWangYCDietzWH. Changes and variability in high levels of low-density lipoprotein cholesterol among children. Pediatrics2010;126:266-73.
10.
National Institute for Health and Clinical Excellence. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia. NICE diagnostics guidance 2 2011. London: NICE, 2011. http://www.nice.org.uk/nicemedia/live/13630/57518/57518.pdf (Accessed May 2012)
